Quadrature Capital »

Black Diamond Therapeutics shares owned by Quadrature Capital

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Quadrature Capital from 13F filings

Historical chart of Quadrature Capital investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Quadrature Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Quadrature Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $80k 38k 2.13

More positions owned by Quadrature Capital

Asml Hldg Nv N Y Registry Shs (ASML)
UnitedHealth (UNH)
Spdr Gold Tr Gold Shs (GLD)
Sap Se Spon Adr (SAP)
Micron Technology (MU)
Sandisk Corp (SNDK)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Circle Internet Group Com Cl A (CRCL)
Crowdstrike Hldgs Cl A (CRWD)
Intel Corporation (INTC)
Toronto Dominion Bk Ont Com New (TD)
Select Sector Spdr Tr State Street Ene (XLE)

View all positions for Quadrature Capital

Top funds holding Black Diamond Therapeutics

NEA Management Company
Acadian Asset Management
Renaissance Technologies
Dimensional Fund Advisors
BlackRock
Connor, Clark & Lunn Investment Management
Mackenzie Financial
Marshall Wace
Arrowstreet Capital, Limited Partnership
Bridgeway Capital Management
Goldman Sachs Group
FMR
Citadel Advisors
UBS Group
Man Group

View all funds holding Black Diamond Therapeutics